Edding Genor Group Holdings Ltd

06998

Company Profile

  • Business description

    Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.

  • Contact

    No. 36 Doukou Road
    Room 406, Building 1
    Hengqin New Area
    Guangdong Province
    Zhuhai
    CHN

    https://www.eddingpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,545

Stocks News & Analysis

stocks

Stop asking if there’s a stock market bubble. Ask this instead.

Why earnings growth might be more important when assessing frothy market conditions.
stocks

Are negative AI narratives holding this ASX share back?

This company is unlikely to be disrupted by AI
stocks

ASX growth share with attractive dividend

Worries about AI overblown.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,023.5011.80-0.13%
CAC 408,367.3317.54-0.21%
DAX 4024,626.8944.33-0.18%
Dow JONES (US)52,182.74306.630.59%
FTSE 10010,484.2223.80-0.23%
HKSE22,762.54264.14-1.15%
NASDAQ25,820.14522.532.07%
Nikkei 22570,116.82648.710.93%
NZX 50 Index13,618.6373.070.54%
S&P 5007,440.4386.411.18%
S&P/ASX 2008,820.8010.70-0.12%
SSE Composite Index4,082.168.260.20%

Market Movers